Alprostadil

규격

745-65-3CAS 번호

212-017-2EC 번호

7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acidIUPAC 명칭

C20H34O5화학식

354.5 g/mol분자량

alprostadil; Prostaglandin E1; 745-65-3; PGE1; Edex; Caverject; Muse; Alprostadilum; Befar; Prostin VR Pediatric; Vitaros; Prink; PGE-1; Prostavasin; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; Caverject Impulse; PGE1alpha; DTXSID9022578; Lipo PGE1; 11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; U-10136; 9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid; F5TD010360; U-10,136; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; DTXCID502578; CHEBI:15544; ONO-1608; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-; NSC-165559; Prostine VR; 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid; Lipo-PGE1; Prostaglandin E1alpha; Viridal duo; NSC165559; 7-((1R,2R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid; Viridal 5; 7-((1R,2R,3R)-3-Hydroxy-2-((1E,3S)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid; Viridal 10; Viridal 20; RefChem:56455; C01EA01; G04BE01; Muse (intraurethral alprostadil suppository); 212-017-2; Prostin; Prostin VR; Prostandin; Vasaprostan; Topiglan; l-Prostaglandin E1; Liprostin; Femprox; Minprog; Alprox-TD; l-PGE1; Lipoprost; Prostivas; (-)-Prostaglandin E1; 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid; Alprostadil(Caverject); ONO 1608; MFCD00077860; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; CHEMBL495; NSC 165559; U 10136; Sugiran; Viridal; Promostan; Alista; Liple; FemLife; RayVa; Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-; (1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid; 7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid; Caverject (TN); SMR000112594; Befar (TN); Prink (TN); Edex (TN); Muse (TN); (-)-Protaglandin E1; SR-01000597593; Alprostadilum [INN-Latin]; Prostin VR pediatric (TN); Alprostadil Prostoglandin E1; Alprostan; Caveject; Eglandin; BML1-F06; Alprostadil CRS; UNII-F5TD010360; SEPA-alprostadil; Alprox TD; Alprostadil(usan); (1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid; HEI-507; NCGC00016535-01; Prostandin 500; Alprostadil; 7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; CAS-745-65-3; XPG; EINECS 212-017-2; (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate; Alprostadil [USAN:USP:INN:BAN:JAN]; SEPA-prostaglandin E1; 11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; PGE1;Prostaglandin E1; AI3-62116; SEPA-PGE1; Prestwick2_001018; Prestwick3_001018; ALPROSTADIL [INN]; ALPROSTADIL [JAN]; ALPROSTADIL [USAN]; ALPROSTADIL [VANDF]; Alprostadil [EP monograph]; ALPROSTADIL [MART.]; SCHEMBL33317; ALPROSTADIL [USP-RS]; ALPROSTADIL [WHO-DD]; BSPBio_001175; BSPBio_001488; MLS000758964; MLS001424250; Alprostadil (ProstaglandinE1); Alprostadil; Prostaglandin E1; BIDD:GT0747; PROSTAGLANDIN E1 [MI]; BPBio1_001293; GTPL1882; orb1307980; Alprostadil (JP18/USP/INN); ALPROSTADIL [ORANGE BOOK]; PGE1, Prostaglandin E1, powder; ALPROSTADIL [USP IMPURITY]; GLXC-20048; HMS1361K10; HMS1571K17; HMS1791K10; HMS1989K10; HMS2052L11; HMS2090L08; HMS2098K17; HMS3268I09; HMS3402K10; HMS3414N09; HMS3648O17; HMS3678N07; HMS3715K17; ALPROSTADIL [USP MONOGRAPH]; EX-A1411; HY-B0131; MSK10682; Tox21_110482; 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid; BDBM50101853; EBC-26712; l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid; LMFA03010134; s1508; AKOS015961103; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11.alpha.,13E,15S)-; AC-6095; CCG-101188; CS-1905; DB00770; FA31828; NC00438; IDI1_033958; SMP2_000271; NCGC00016535-11; NCGC00016535-19; NCGC00025234-02; NCGC00025234-03; NCGC00025234-04; NCGC00025234-05; AS-16360; Prostaglandin E1, PGE1, 745-65-3; Alprostadil 100 microg/mL in Acetonitrile; 11,15-Dihydroxy-9-oxoprost-13-en-1-oate; AB00514004; NS00009541; P6956; ST50826271; T1626; Alprostadil, meets USP testing specifications; C04741; C76381; D00180; Prostaglandin E1, >=98% (HPLC), synthetic; AB00514004-06; AB00514004-08; AB00514004_09; EN300-22411483; F826286; Q579348; SR-01000946253; SR-01000597593-1; SR-01000597593-5; SR-01000597593-6; SR-01000946253-1; BRD-K52459643-001-06-0; BRD-K52459643-001-10-2; BRD-K52459643-001-15-1; BRD-K52459643-001-17-7; (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate; (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid; 11alpha,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid; Alprostadil, European Pharmacopoeia (EP) Reference Standard; (13e)-(15s)-11alpha,15-dihydroxy-9-oxoprost-13-enoic acid; (11|_,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; (11|A,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; (11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoic acid; 11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0); 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate; 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid; Alprostadil, United States Pharmacopeia (USP) Reference Standard; (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate; (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid; (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate; (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid; (11alpha,12alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclop entaneheptanoic acid; Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l-; Cyclopentaneheptanoic acid, 3alpha-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-; PGE1; Alprostadil; 9-oxo-11|A,15S-dihydroxy-prost-13E-en-1-oic acid; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15S)-; Prostaglandin E1, synthetic, powder, BioReagent, suitable for cell culture; 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid; Prostaglandin E1, powder, gamma-irradiated, BioXtra, suitable for cell culture; 7-[5-((1E)(3S)-3-hydroxyoct-1-enyl)(1R,4R,5R)-4-hydroxy-2-oxocyclopentyl]hepta noic acid동의어